Cornerstone Wealth Group’s Sanofi SNY Stock Holding History

Cornerstone Wealth Group’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-98,434	Closed	-$5.28M	–	156
2023 Q3	$5.28M	Sell	98,434 -1,144	-1%	-$61K	0.94%	27
2023 Q2	$5.37M	Buy	+99,578	New	+$5.36M	0.97%	30

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Cornerstone Wealth Group's SNY Position: Q4 2023 in Review

Cornerstone Wealth Group sold out of Sanofi (SNY) in Q4 2023, closing a stake of 98,434 shares — an estimated $5.28M sold.

Cornerstone Wealth Group first reported a position in SNY in Q2 2023 and held it in 2 quarters. The position peaked at $5.37M in Q2 2023. 707 funds tracked by Wall St. Rank hold SNY as of Q4 2023.

Cornerstone Wealth Group reported no remaining Sanofi position as of Q4 2023 after selling out during the quarter.
Cornerstone Wealth Group sold 98,434 Sanofi shares in Q4 2023, an estimated $5.28M.
Cornerstone Wealth Group first reported a position in Sanofi in Q2 2023 and held it in 2 quarters.
Cornerstone Wealth Group's Sanofi position peaked at $5.37M in Q2 2023.
707 funds tracked by Wall St. Rank held Sanofi as of Q4 2023.

Based on Cornerstone Wealth Group's 13F filing for Q4 2023, filed 29 Jan 2024.